Annotation and classification of biological space in chemogenomics
A large majority of current drugs have bioactivity due to their binding to a protein, without practically exploiting any of the three other types of macromolecule within biological systems: polysaccharides, lipids and nucleic acids. It is therefore very limited today to discuss targets in general for which we can develop molecules with properties close to those of drugs.
KeywordsNucleic Acid Biological System Large Majority Current Drug Biological Space
Unable to display preview. Download preview PDF.
- HUMPHREY P.P.A., BARNARD E.A. (1998) International Union of Pharmacology. XIX. The IUPHAR Receptor Code: a proposal for an alphanumeric classification system. Pharmacol. Rev. 50: 271-277Google Scholar
- HUMPHREY P.P.A., BARNARD E.A., BONNER T.I., CATTERALL W.A., DOLLERY C.T., FREDHOLM B.B., GODFRAIND T., HARMER A.J., LANGER S.Z., LAUDET V., LINBIRD L.E., RUFFOLO R.R., SPEDDING M., VANHOUTTE P.M., WATSON S.P. (2000) The IUPHAR Receptor Code. In The IUPHAR Compendium of Receptor Characterization and Classification, 2nd Edition, IUPHAR Media, London: 9-23Google Scholar
- MESTRES J. (2004) Computational chemogenomics approaches to systematic knowledge-based drug discovery. Curr. Opin. Drug Discov. Dev. 7: 304-313Google Scholar
- Nomenclature Working Party (2004) Nomenclature Guidelines for Authors. Br. J. Pharmacol. 141: 13-17Google Scholar